IP Library Granted Patent US 12,186,334
Granted Patent B2
US 12,186,334 · App. 17/874,382 · Granted Jan 7, 2025

High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions

Inventors: Christopher Michael Kevin Springate (Richmond, CA); Ian Millet (Richmond, CA); Sailesh Haresh Daswani (Richmond, CA); Hesong Sun (Richmond, CA)
Assignee: ARC Medical Inc.
A61K31/737A61P41/00C08B37/0003C08B37/0063
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,186,334
App. No.
17/874,382
Granted
Jan 7, 2025
Kind
B2
Abstract

High-molecular-weight fucan compositions comprising a therapeutically effective, medically acceptable fucan in a composition comprising wherein the fucan, for example, has a molecular weight distribution in which more than 60% w/w of the composition has a molecular weight above 100 kDa.

Claims (15)

1. A high-molecular-weight fucan wherein the high-molecular-weight fucan consists of a molecular weight distribution wherein at least about 92% w/w of the molecular weight distribution of the fucan is greater than 100 kDa when measured using an aqueous gel permeation chromatography set up consisting of:

one 300 mm analytical gel permeation chromatography column with a 7.8 mm inner diameter packed with hydroxylated polymethacrylate-based gel, having an effective molecular weight range of between about 50 kDa and about 5,000 kDa, one 300 mm analytical gel permeation chromatography column with a 7.8 mm inner diameter packed with hydroxylated polymethacrylate-based gel, having an effective molecular weight range of between about 1 kDa and about 6,000 kDa and one 40 mm guard column with a 6 mm inner diameter packed with hydroxylated polymethacrylate-based gel, the two analytical gel permeation chromatography columns and the one guard column contained in a column compartment at about 30° C.;

a refractive index detector at about 30° C.;

0.1M sodium nitrate mobile phase run at 0.6 mL/min; and

quantification against a peak molecular weight standard curve consisting of a first dextran standard with a peak molecular weight of about 2,200 kDa, a second dextran standard with a peak molecular weight of between about 720 kDa and about 760 kDa, a third dextran standard with a peak molecular weight between about 470 kDa and about 510 kDa, a fourth dextran standard with a peak molecular weight between about 370 kDa and about 410 kDa, a fifth dextran standard with a peak molecular weight between about 180 kDa and about 220 kDa, and a sixth dextran standard with a peak molecular weight between about 40 kDa and 55 kDa.

2. The high-molecular-weight fucan of claim 1 , comprising a weight average molecular weight between about 100 kDa and 10,000 kDa.

3. The high-molecular-weight fucan of claim 2 , wherein the weight average molecular weight is between about 370 kDa and 1900 kDa.

4. The high-molecular-weight fucan of claim 1 , comprising a number average molecular weight between about 50 kDa and 3,000 kDa.

5. The high-molecular-weight fucan of claim 1 , wherein at least 55% w/w of the distribution is greater than about 200 kDa.

6. The high-molecular-weight fucan of claim 1 , wherein at least 22% w/w of the distribution is greater than about 500 kDa.

7. A high-molecular-weight fucan wherein the high-molecular-weight fucan consists of a molecular weight distribution wherein between about 61% w/w and 80% w/w of the molecular weight distribution of the fucan is between about 200 kDa and 1600 kDa when measured using an aqueous gel permeation chromatography set up consisting of:

one 300 mm analytical gel permeation chromatography column with a 7.8 mm inner diameter packed with hydroxylated polymethacrylate-based gel, having an effective molecular weight range of between about 50 kDa and about 5,000 kDa, one 300 mm analytical gel permeation chromatography column with a 7.8 mm inner diameter packed with hydroxylated polymethacrylate-based gel, having an effective molecular weight range of between about 1 kDa and about 6,000 kDa and one 40 mm guard column with a 6 mm inner diameter packed with hydroxylated polymethacrylate-based gel, the two analytical gel permeation chromatography columns and the one guard column contained in a column compartment at about 30° C.;

a refractive index detector at about 30° C.;

0.1M sodium nitrate mobile phase run at 0.6 mL/min; and

quantification against a peak molecular weight standard curve consisting of a first dextran standard with a peak molecular weight of about 2,200 kDa, a second dextran standard with a peak molecular weight of between about 720 kDa and about 760 kDa, a third dextran standard with a peak molecular weight between about 470 kDa and about 510 kDa, a fourth dextran standard with a peak molecular weight between about 370 kDa and about 410 kDa, a fifth dextran standard with a peak molecular weight between about 180 kDa and about 220 kDa, and a sixth dextran standard with a peak molecular weight between about 40 kDa and 55 kDa.

Assignments (2)
CHANGE OF NAME Recorded Aug 20, 2024
From: ARC MEDICAL DEVICES INC.
To: ARC MEDICAL INC.
Reel/Frame 068707/0019 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: SPRINGATE, CHRISTOPHER MICHAEL KEVIN; DASWANI, SAILESH HARESH; SUN, HESONG; MILLET, IAN
To: ARC MEDICAL DEVICES INC.
Reel/Frame 068296/0712 →
Continuity (17)
Continuation 17260272
Provisional Application 62861223 · Jun 13, 2019
Provisional Application 62861228 · Jun 13, 2019
Provisional Application 62861235 · Jun 13, 2019
Provisional Application 62793654 · Jan 17, 2019
Provisional Application 62755318 · Nov 2, 2018
Provisional Application 62755328 · Nov 2, 2018
Provisional Application 62755311 · Nov 2, 2018
Provisional Application 62722137 · Aug 23, 2018
Provisional Application 62722135 · Aug 23, 2018
Provisional Application 62713413 · Aug 1, 2018
Provisional Application 62713392 · Aug 1, 2018
Provisional Application 62713399 · Aug 1, 2018
Provisional Application 62711364 · Jul 27, 2018
Provisional Application 62711372 · Jul 27, 2018
Provisional Application 62711335 · Jul 27, 2018
Related Publication 20230140869A1 · May 11, 2023
References Cited (135)
US 5616595A · Chu et al. · 1997 [cited by applicant]
US 5772900A · Yorita et al. · 1998 [cited by applicant]
US 6868715B1 · Carnahan et al. · 2005 [cited by applicant]
US 8426381B2 · Thibodeau et al. · 2013 [cited by applicant]
US 8466125B2 · Springate · 2013 [cited by applicant]
US 10139378B2 · Kang · 2018 [cited by applicant]
US 20030224346A1 · Karlsson · 2003 [cited by applicant]
US 20040014179A1 · Thwaites · 2004 [cited by applicant]
US 20070122875A1 · Sakai · 2007 [cited by applicant]
US 20070298508A1 · Deslauriers et al. · 2007 [cited by applicant]
US 20080063682A1 · Cashman et al. · 2008 [cited by applicant]
US 20090105910A1 · Hatano et al. · 2009 [cited by applicant]
US 20090170801A1 · Hao · 2009 [cited by applicant]
US 20090170810A1 · Hao · 2009 [cited by applicant]
US 20110021457A1 · Springate · 2011 [cited by applicant]
US 20110172156A1 · Dockal et al. · 2011 [cited by applicant]
US 20120237572A1 · Grassauer · 2012 [cited by examiner]
US 20170328873A1 · Kang · 2017 [cited by applicant]
US 20180051097A1 · Springate et al. · 2018 [cited by applicant]
CA 2769147 · 2011 [cited by applicant]
CN 1437650 · 2003 [cited by applicant]
CN 1985846 · 2007 [cited by applicant]
CN 101011411 · 2007 [cited by applicant]
CN 101037483 · 2007 [cited by applicant]
CN 101156664 · 2008 [cited by applicant]
CN 101659709 · 2010 [cited by applicant]
CN 102665733 · 2012 [cited by applicant]
CN 102911281 · 2013 [cited by applicant]
CN 202778304 · 2013 [cited by applicant]
CN 104586878 · 2015 [cited by applicant]
CN 105399848 · 2016 [cited by applicant]
CN 106176798 · 2016 [cited by applicant]
CN 106832022 · 2017 [cited by applicant]
CN 107155305 · 2017 [cited by applicant]
CN 10738266 · 2017 [cited by applicant]
CN 112513165 · 2019 [cited by applicant]
EA 201270186 · 2012 [cited by applicant]
EA 25808 · 2017 [cited by applicant]
EP 100843 · 1984 [cited by applicant]
EP 0567914 · 1993 [cited by applicant]
EP 1277834 · 2003 [cited by applicant]
JP 10182703 · 1998 [cited by applicant]
JP 2005507077 · 2005 [cited by applicant]
JP 2005508893 · 2005 [cited by applicant]
JP 2005517955 · 2005 [cited by applicant]
JP 2007504273 · 2007 [cited by applicant]
JP 2010519383 · 2010 [cited by applicant]
JP 2013500274 · 2013 [cited by applicant]
JP 2013517285 · 2013 [cited by applicant]
JP 2013180994 · 2013 [cited by applicant]
JP 2014124579 · 2014 [cited by applicant]
JP 2016505083 · 2016 [cited by applicant]
JP 2016128491 · 2016 [cited by applicant]
JP 2017206542 · 2017 [cited by applicant]
JP 2018513383 · 2018 [cited by applicant]
KR 20060031936 · 2006 [cited by applicant]
KR 20060051439 · 2006 [cited by applicant]
KR 20100138440 · 2010 [cited by applicant]
KR 20160011952 · 2016 [cited by applicant]
KR 101950246 · 2019 [cited by applicant]
PH 12012500177 · 2012 [cited by applicant]
RU 2247574 · 2005 [cited by applicant]
RU 2497525 · 2013 [cited by applicant]
RU 2591161 · 2016 [cited by applicant]
RU 2015135635 · 2017 [cited by applicant]
RU 2638859 · 2018 [cited by applicant]
WO WO2008031332 · 2008 [cited by applicant]
WO WO2008041799 · 2008 [cited by applicant]
WO WO2008103234 · 2008 [cited by applicant]
WO WO2010110223 · 2010 [cited by applicant]
WO WO2011011881 · 2011 [cited by applicant]
WO WO2014113836 · 2014 [cited by applicant]
WO WO2016117599 · 2016 [cited by applicant]
WO WO2017042603 · 2017 [cited by applicant]
WO WO2017160739 · 2017 [cited by applicant]
WO WO2020176989 · 2020 [cited by applicant]
WO WO2020176990 · 2020 [cited by applicant]
Abstracts of the 25th Annual Meeting of ESHRE, Amsterdam, The Netherlands, Jun. 28, 2009-Jul. 1, 2009. [cited by applicant]
Ale et al., “Important Determinants for Fucoidan Bioactivity: A Critical Review of Structure-Function Relations and Extraction Methods for Fucose-Containing Sulfated Polysaccharides from Brown Seaweeds,” Mar. Drugs, Oct… [cited by applicant]
Baba et al., “Effects of extraction solvent on fucose content in fucoidan extracted from brown seaweed ( [cited by applicant]
Balboa et al., “Valorization of Sargassum muticum Biomass According to the Biorefinery Concept,” Marine Drugs, Jun. 11, 2015, vol. 13, pp. 3745-3760. [cited by applicant]
Cashman, Johanne et al., “Fucoidan Film Safely Inhibit Surgical Adhesions in a Rat Model,” Journal of Surgical Research, vol. 171, pp. 495-603, 2011. [cited by applicant]
Chen et al., “A new extraction method for fucoidan from the soaked water of brown seaweed ( [cited by applicant]
Chizhov et al., “A study of fucoidan from the brown seaweed Chorda filum,” Carbohydrate Research, Jul. 20, 1999, vol. 320, pp. 108-119. [cited by applicant]
Corrigan, N. et al., “Copolymers with Controlled Molecular Weight Distributions and Compositional Gradients through Flow Polymerization,” Macromolecules, 2018, vol. 51(12), pp. 4553-4563. [cited by applicant]
Croci, D.O. et al., “Fucans, but not Fucomannoglucornonas, Determine the Biological Activities of Sulfated Polysaccharides from [cited by applicant]
Cumashi, Albana et al., “A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds,” Glycobiology, vol. 17, No. 5, pp. 541-5… [cited by applicant]
Deniaud-Bouet, E. et al., “Chemical and enzymatic fractionation of cell walls from Fucals: insights into the structure of the extracellular matrix of brown algae,” Annals of Botany, May 29, 2014, vol. 114, pp. 1203-1216. [cited by applicant]
Fernando et al., “A fucoidan fraction purified from Chnoospoora minima: a potential inhibitor of LPS-Induced inflammatory responses,” International Journal of Biological Macromolecules, 2017, vol. 104, pp. 1185-1193. [cited by applicant]
Fitton, Janet et al., “Therapies from Fucoidan: An Update” Marine Drugs, vol. 13, No. 9, Sep. 6, 2016, pp. 5920-5946. [cited by applicant]
Fujikawa, Tatsuo et al., “Occurrence of Fucoidan and Fucoidan Analogues in Brown Seaweed,” Agricultural Chemistry, vol. 49, No. 9, 1975, pp. 455-461. [cited by applicant]
Greco et al., “A Simple and Effective Method for High Quality Co-Extraction of Geonomic DNA and Total RNA from Low Biomass Ectocarpus siliculosus, the Model Brown Alga,” PLOS One, May 27, 2014, vol. 9(5), pp. 1-13. [cited by applicant]
“Guidance for Industry, Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,” U.S. Department of Health and Human Services Food and Drug Administration Cente… [cited by applicant]
Hahn et al., “Novel Procedures for the extraction of fucoidan from brown algae,” Process Biochemistry, Jun. 23, 2012, vol. 47, pp. 1691-1698. [cited by applicant]
Haroun-Bouhedja et al., “Relationship between Sulfate Groups and Biological,” Thrombosis Research, Dec. 1, 2000, vol. 100(5), pp. 453-459. [cited by applicant]
Hoagland, “The Complex Carbohydrates and Forms of Sulphur in Marine Algae of the Pacific Coast,” The Journal of Biological Chemistry, 1915, vol. 23(1), pp. 287-297. [cited by applicant]
International Search Report and Written Opinion relating to International Patent Application No. PCT/CA2019/051026, mailed Oct. 16, 2019, 17 pages. [cited by applicant]
International Search Report and Written Opinion relating to International Patent Application No. PCT/CA2019/051027, mailed Nov. 20, 2019, 15 pages. [cited by applicant]
International Search Report and Written Opinion relating to International Patent Application No. PCT/CA2019/051030, mailed Nov. 27, 2019, 24 pages. [cited by applicant]
International Search Report and Written Opinion relating to International Patent Application No. PCT/CA2019/051028, mailed Nov. 15, 2019, 27 pages. [cited by applicant]
International Search Report and Written Opinion relating to International Patent Application No. PCT/CA2019/051029, mailed Dec. 12, 2019, 15 pages. [cited by applicant]
International Search Report and Written Opinion relating to International Patent Application No. PCT/CA2020/050294, mailed May 29, 2020, 8 pages. [cited by applicant]
International Search Report and Written Opinion relating to International Patent Application No. PCT/CA2020/050295, mailed Jun. 5, 2020, 12 pages. [cited by applicant]
Kim, et al., “Molecular weight and sulfate content modulate the inhibition of a-amylase by fucoidan relevant for type 2 diabetes management,” PharmaNutrition, Jul. 2015, vol. 3(3), pp. 108-114. [cited by applicant]
Kopplin, Georg et al., “Structural Characterization of Fucoidan from Laminaria hyperborean: Assessment of Coagulation and Inflammatory Properties and Their Structure-Fucan Relationship,” Applied Bio Materials, 2018, vol… [cited by applicant]
Koyanagi et al., “Oversulfation of Fucoidan Enhances its Anti-Angiogenic and Anti-Tumor Activities,” Biochemical Pharmacology, Jan. 15, 2003, vol. 65(2), pp. 173-179. [cited by applicant]
Lee et al., “Variation in Fucoidan Contents and Monosaccharide Compositions of Korean Undaria pinnatifida (Harvey) Surigar (Phaephyta),” Algae, vol. 21:1, 2006, 157-160. [cited by applicant]
Li et al., “Fucoidan: Structure and Bioactivity,” Molecules, Aug. 12, 2008, vol. 13, pp. 1671-1695. [cited by applicant]
Ly et al., “Studies on Fucoidan and its Production from Vietnamese Brown Seaweeds,” ASEAN Journal on Science and Technology for Development, 2005, vol. 22(4), pp. 371-380. [cited by applicant]
Mabeau, Serge et al., “Fractionation and Analysis of Fucans from Brown Algae”, Phytochemistry, vol. 29, No. 8, pp. 2441-2445, 1990. [cited by applicant]
Makarenkova, I D et al., “Sulfated polysaccharides of brown seaweeds are ligands of toll-like receptors,” Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, SP Maik Nauka, Interperiodica, Dordrecht, vol. 6… [cited by applicant]
Men'Shova, R.V. et al., “Effect of pretreatment conditions of brown algae by supercritical fluids on yield and structural characteristics of fucoidans,” Chemistry of Natural Compounds, Jan. 2013, vol. 48, No. 6, pp. 923… [cited by applicant]
Mulloy, Barbara et al., “Sulfated fucans from Echinoderms have a regular tetrasaccharide repeating unit defined by specific patterns of sulfation at the 0-2 and 0-4 positions Analysis View project,” Oct. 1, 1994, DOI: 1… [cited by applicant]
Nishino, Takashi et al., “Anticoagulant and antithrombin activities of oversulfated fucans,” Carbohydrate Research, 229 (1992) 355-362. [cited by applicant]
Pereira, M.S. et al., “Is there a correlation between structure and anticoagulant action of sulfated galactans and sulfated fucans,” Glycobiology, Oct. 1, 2002, vol. 12(10), pp. 573-580, downloaded from the internet htt… [cited by applicant]
Qiu et al., “Effect of oversulfation on the chemical and biological properties of fucoidan,” Carbohydrate Polymers, Nov. 21, 2005, vol. 63, pp. 224-228. [cited by applicant]
Regis et al., “Regioselective desulfation of sulfated L-fucopyranoside by a new sulfoesterase from the marine mollusk Pecten maximus Application to the structural stud of agal fucoidan ( [cited by applicant]
Saboural, P, et al. “Purification of a Low Molecular Weight Fucan for SPECT Molecular Imaging of Myocardial Infarction,”, Marine Drugs 2014, vol. 12, pp. 4851-4867. [cited by applicant]
Sakai, Takeshi et al., Polymers, Jul. 2006, vol. 55, pp. 488-489. [cited by applicant]
Seimon, T.A. et al., “Combinational pattern recognition receptor signaling alters the balance of life and death in macrophages,” PNAS Cell Biology (2006), vol. 103, No. 52, pp. 19794-19799. [cited by applicant]
Sezer, A.D et al., “Preparation of fucoidan-chitosan hydrogel and its application as burn healing accelerator on rabbits,” Biol Pharm Bull. 2008, vol. 31(12), pp. 2326-2333. [cited by applicant]
Simurant et al., “Purification and Characterization of Fucoidan From the Brown Seaweed [cited by applicant]
Soeda et al., “Preparation of oversulfated fucoidan fragments and evaluations of their antithrombotic activities,” Thrombosis Research, Nov. 1, 1993, vol. 72(3), pp. 247-256. [cited by applicant]
Soeda et al., “Oversulfated fucoidan and heparin suppress endotoxin induction of plasminogen activator inhibitor-1 in cultured human endothelial cells: their possible mechanism of action,” Biochimica et Biophysica Acta … [cited by applicant]
Usui et al., “Isolation of Highly Purified Fucoidan from Eisenia bicyclis and Its Anticoagulant and Antitumor Activities,” Agric. Biol. Chem, Mar. 12, 1980, vol. 44(8), pp. 1965-1966. [cited by applicant]
Wang, “Impacts of Processing and Storage Methods on the Yield and Composition of Fucoidan from Undaria pinnatifida,” Auckland University of Technology, Nov. 2014, pp. 1-71. [cited by applicant]
Wijesinghe et al., “Biological activities and potential industrial applications of fucose rich sulfated polysaccharides and fucoidans isolated from brown seaweeds: A review,” Carbohydrate Polymers, Dec. 24, 2011, vol. 8… [cited by applicant]
Wu et al., “Liquid-Liquid Extraction of Fucoidan Leached from Brown Seaweeds,” The Chinese Journal of Process Engineering, Feb. 2002, ISSN http://en.cnki.com.cn/Article_en/CJFDTotal-HGYJ200202006.htm. [cited by applicant]
Wu, “Solvent Extraction of Fucoidan in Aqueous Solution with Quaternary Ammonium Salt as Extractant,” Chinese High Technology Letters, Aug. 2001, ISSN http://en.cnki.com.cn/Article_en/CJFDTotal-GJSX200108009.htm. [cited by applicant]
Wu et al., “Structural Analysis and Anticoagulant Activities of the Novel Sulfated Fucan Possessing a Regular Well-Defined Repeating Unit from Sea Cucumber,” Marine Drugs, Apr. 13, 2015, vol. 13, p. 2063-2084. [cited by applicant]
Xing et al., “Extraction and Separation of Fucoidan from Laminaria japonica with Chitosan as Extractant,” Hindawi Publishing Corporation, 2013, pp. 1-4. [cited by applicant]
Zayed et al., “Physiochemical and Biological Characterization of Fucoidan from Fucus vesiculosus Purified by Dye Affinity Chromatography,” Marine Drugs, Apr. 15, 2016, vol. 14(4), pp. 1-15. [cited by applicant]
Zhang, H. et al., “Control of molecular weight distribution for polypropylene obtained by commercial Ziegler-Natta catalyst: effect of temperature,” Polym. Bull. 2011, vol. 67, pp. 1519-1527. [cited by applicant]
Zhao, Yu et al., “Fucoidan Extracted from Undaria pinnatifida: Source for Nutraceuticals/Functional Foods,” Marine Drugs, 2018, vol. 16: 321, 17 pages. [cited by applicant]
Zhao et al., “The Removal of Lead from Purified Fucoidan Extracted from Kelp [cited by applicant]